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Abstract
To test the role of wtPIT-1 (PITWT) or PIT-1 (R271W) (PIT271) in somatolactotroph cells,
we established, using inducible lentiviral vectors, sublines of GH4C1 somatotroph cells that
allow the blockade of the expression of endogenous PIT-1 and/or the expression of PITWT
or PIT271, a dominant negative mutant of PIT-1 responsible for Combined Pituitary Hor-
mone Deficiency in patients. Blocking expression of endogenous PIT-1 induced a marked
decrease of cell proliferation. Overexpressing PITWT twofold led also to a dose-dependent
decrease of cell proliferation that was accompanied by cell death. Expression of PIT271 in-
duced a strong dose-dependent decrease of cell proliferation accompanied by a very pro-
nounced cell death. These actions of PIT271 are independent of its interaction/competition
with endogenous PIT-1, as they were unchanged when expression of endogenous PIT-1
was blocked. All these actions are specific for somatolactotroph cells, and could not be ob-
served in heterologous cells. Cell death induced by PITWT or by PIT271 was accompanied
by DNA fragmentation, but was not inhibited by inhibitors of caspases, autophagy or necro-
sis, suggesting that this cell death is a caspase-independent apoptosis. Altogether, our re-
sults indicate that under normal conditions PIT-1 is important for the maintenance of cell
proliferation, while when expressed at supra-normal levels it induces cell death. Through
this dual action, PIT-1 may play a role in the expansion/regression cycles of pituitary lacto-
troph population during and after lactation. Our results also demonstrate that the so-called
“dominant-negative” action of PIT271 is independent of its competition with PIT-1 or a block-
ade of the actions of the latter, and are actions specific to this mutant variant of PIT-1.
Introduction
POU1F1 (PIT-1), is a pituitary- and lineage-specific POU homeodomain transcription factor
that was among the first vertebrate transcription factors identified as having a determinant role
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in the development of specific cell lineages [1,2]. It has a crucial role in the terminal differentia-
tion and expansion of the somatolactotroph and thyrotroph lineages during pituitary develop-
ment as well as in the physiological regulation of the expression of the genes of prolactin
(PRL), growth hormone (GH) and thyroid-stimulating hormone (TSHß) [3]. In accordance
with this role, mutations of Pit-1 lead to Combined Pituitary Hormone Deficiency (CPHD),
characterized by the lack of production of PRL, GH and TSHß due to the absence of the corre-
sponding pituitary lineages [4–6].
A number of evidences suggest that PIT-1 plays a role in the regulation of proliferation and/
or survival of its target cell populations. One is the fact that mutations of Pit-1 lead to a marked
pituitary hypoplasia, with loss of the somatolactotroph and thyrotroph lineages [7], related to a
decrease in cell proliferation and increase in cell death [8]. A more direct evidence reported
soon after the discovery of Pit-1 is that an asRNA specific for Pit-1 leads to a decrease of cell
proliferation in a rat somatolactotroph cell line [9]. More recently we have shown that the ex-
pression of dominant negative pathogenic form of PIT-1, PIT-1(R271W) (PIT271) leads to cell
death, supporting the hypothesis that PIT-1 is required for survival and proliferation of soma-
tolactotroph cells [10,11]. However, seemingly contradictory results have been published more
recently by the group of C. V. Alvarez [12,13] that has described that an increase of intracellu-
lar PIT-1, induced by the Ret tyrosine-kinase receptor or by direct transfection, leads to death
of the cells. Moreover, recently we obtained results ourselves suggesting that PIT-1 overexpres-
sion in specific conditions could decrease cell proliferation [10].
To clarify this contradiction, we have decided to re-evaluate the role of PIT-1 and the effect
of PIT271 using a new approach. For that we developed an experimental model that allowed to
test the action of PIT-1 and its blockade independent of PIT271 and with more reliable tools
than the asRNA's used in the original 1991 study [9], and also to isolate the action of PIT271
from its interaction with endogenous PIT-1. Note that besides allowing to address the role of
PIT-1, this approach allowed also to examine whether the action of PIT271 is indeed linked to
its antagonization of endogenous PIT-1 as previously hypothesized.
Our results demonstrate that, despite the appearances, there is no real contradiction be-
tween the two sets of results, as we observed that both the blockade of the expression of PIT-1
and its overexpression lead to cell death and altered proliferation. Thus, PIT-1 may switch in
somatolactotroph cells, in a dose-dependent fashion, between a role of cell maintenance and
one of induction of cell death. Second, we show that PIT271 induces cell death and decreases
cell proliferation, confirming our earlier results. However, these actions of PIT271 are indepen-
dent of its interaction with endogenous PIT-1.
Methods
Vector constructions
siRNA's for rat Pit-1 were ordered from Ambion. To construct the shRNA lentiviral vectors,
the sequences coding for the selected siRNA's were extended by three bases and inserted into
an miR-30-based oligonucleotide designed as defined by Chang et al. [14] (Fig. 1A). The oligo-
nucleotides were then ligated into the pInducer-10 lentiviral vector [15] (Fig. 1B). Rat wild type
PIT-1 (PITWT) or PIT271 expressing lentiviral vectors were constructed by inserting the cod-
ing sequences for the protein into the pInducer-20 lentiviral vector, downstream of the TRE2
promoter [15] (Fig. 1B). Note that to avoid subsequent targeting of the Pit-1mRNA tran-
scribed from the vector by co-expressed Pit-1 shRNA's, conservative codon changes were intro-
duced into the cDNA sequences corresponding to the regions targeted by the shRNA's in
endogenous Pit-1 (Fig. 1C). Lentiviral vectors were produced in 293T cells. Lentiviral vectors
transducing eGFP, hPITWT or hPIT271 have been described earlier [11].
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Analysis of gene expression
For RT-qPCR cells, total RNA was isolated and purified from cells using Trizol (Life Technolo-
gies) according to the procedure given by the manufacturer. Following reverse transcription
using random primers and M-MLV reverse transcriptase, qPCR was performed using an ABI
7500Fast station and the SYBR-Green PCR master mix (2x Fast Master Mix kit from KAPA
Biosystems). Specific primers were designed with AmplifX (http://crn2m.univ-mrs.fr/pub/
amplifx-dist). Normalization of the results for Pit-1 was done in two steps: first using known
quantities of a Pit-1 plasmid used as external standards to obtain an evaluation of the absolute
number of copies, second relative to actin to compensate for technical variations. Note that the
results were the same when quantification was achieved through normalization relative to the
Fig 1. Constructs used in this study. A. Oligonucleotides used for the construction of the shRNA expressing lentiviral vectors. In red the target sequence,
in blue the antisense (guide) strand, in green the sequence corresponding to the miR-30 'head'. The sequence of the Ambion siRNA on which a given shRNA
construct was based is indicated in italics, underlined is the base that has been modified in order to introduce a bulge into the miRNA produced. B. Scheme of
the pInducer lentiviral vectors used [15]. Expression of the red fluorescent protein (RFP) and the coupled miR30 construct containing the inserted shRNA
sequence (pInducer-10) or of the inserted CDS (pInducer-20) is driven by the synthetic TRE2 promoter regulated in a doxycycline-dependent manner by the
rtTA3 transcription factor expressed constitutively by the Ubc promoter. The vectors express resistance markers, allowing selection of infected cells by
puromycin or G418. C. Modifications introduced in the sequences targeted by the shRNA's in the coding sequence of PIT-1. The CDS with these
modifications have been used to construct the pInducer-20 based expression vectors. The wt sequence is given in the upper lines, the modified sequence
with the introduced changes indicated in capital letter in the middle lines. The lower line indicated the amino acids corresponding to the codons. The numbers
in parentheses indicate the ordinal number of the first codon.
doi:10.1371/journal.pone.0120010.g001
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quantity of input RNA. We used two different forward primers for Pit-1 (or Pit271) targeted to
the sequence that has been modified for the expression from the lentiviral vector (see above),
permitting separate measurements and direct comparison of endogenous and exogenous
mRNA's. Note that we have verified that the RT efficiencies were equivalent for these two
mRNA species. Quantification for genes other than Pit-1 was done using the ΔΔCt method. Ex-
pression analysis in human pituitary adenomas was performed by RT-qPCR using a TaqMan
assay with specific probes, and using ß-glucuronidase as normalizing gene. All primers and
probes are listed in Table 1.
Western-blots
Cell extracts were prepared using a buffer containing Tris-HCl (50 mM pH 7,4), NaCl
(150mM), EDTA (1mM), NP40 (1%), deoxycholate (0,25%) and "Complete Protease Inhibitor"
cocktail (Roche, 0.4%). Proteins (10 μg per lane) were separated by SDS-PAGE and transferred
onto PVDF Low Fluorescence membrane (Millipore). Proteins were detected by incubation
with primary antibodies against PIT-1 (mouse monoclonal clone A-1, Santa-Cruz, 1:700),
PRL (rabbit polyclonal, A.F. Parlow, National Hormone and Pituitary program, 1:200 final di-
lution), p19ARF (rabbit polyclonal 07–543, Upstate, or rabbit polyclonal ab80 Abcam, final
dilution 1:1000 for both), P53 (monoclonal C12 Cell Signaling, or monoclonal PAb421 Calbio-
chem, final dilution 1:1000 for both) or ß-actin (rabbit polyclonal AC-15, Sigma, 1:5000 final
dilution), followed by incubation with secondary antibodies coupled to Q-dots (Q-Dot 655
anti-rabbit or Q-Dot 565 anti-mouse IgG conjugates (Molecular Probes, 1:1000 final dilution),
and visualization using GBox XT4 (Syngene) with UV epi-illumination and specific filters
(665BP20 and 565BP20), or coupled to fluorescent labels (Alexa-Fluor 647 or 555, Molecular
Probes, 1:1000 final dilution), and visualization using Typhoon FLA9000 (GE Healthcare).
Quantification of bands was done with ImageQuant TL (GE Healtcare)
Cell culture
Rat somatolactotroph GH4C1 cells (ATCC) were grown in F10 medium (Life Technologies)
supplemented with horse serum (15%) and fetal bovine serum (5%) at 37°C in the presence of
5% CO2. African green monkey kidney CV1 cells (ATCC) were grown in DMEM (Life Tech-
nologies) supplemented with fetal bovine serum (10%) at 37°C in the presence of 5% CO2.
To evaluate the effect of siRNA's on the expression of Pit-1, cells on 24-well plates were
transfected with 60 pmol/well siRNA (final concentration 100 nM), using Lipofectamine (Life
Technologies) according to the manufacturer's instructions, and lysed 48h later.
Lentiviral infection was done using the filtered viral supernatants of the 293T producer
cells, in the presence of 4 μg/ml Polybrene. Antibiotic selection (pInducer-10-based vectors:
puromycin, 10 μg/ml, pInducer-20-based vectors: G418, 600 μg/ml) was started two days after
infection. To obtain shRNA-expressing clones, 1000 puromycin-resistant cells were plated
onto 100 mm plates and clones were picked manually. Induction of shRNA expressed by pIn-
ducer-10, or of Pit-1 or Pit271 expressed by pInducer-20 was obtained by adding doxycycline
to the medium. The inducer was maintained for the whole duration of the experiment and re-
freshed every second day.
To evaluate proliferation, 30 000 cells/well (GH4C1 cells) and 15 000 cells/well (CV1 cells)
were plated on 24-w plates. Doxycycline (1 μg/ml) was added next day (D0) to induce expres-
sion of shRNA and/or of Pit-1 or Pit271 and maintained throughout the experiment. Cells
were counted starting on D0 using the Specter cell counter (Millipore) from triplicate wells. Ex-
periments were repeated four times. Statistical analysis was performed on the data obtained for
Dual Role of PIT-1
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Table 1. List of primers used for RT-qPCR quantiﬁcation.
Target Primers
Actin Fw: 5'-ttgctgacaggatgcagaaggaga
Rev: 5'-tcgtactcctgcttgctgatcca
Aatf Fw: 5'-aatgctcacctgaaggacttggac
Rev: 5'-gaaactcaggagcttgctaagcac
Bag1 Fw: 5'-acagtgagccaattgtccaagacc
Rev: 5'-acagatacctccaagtccttcagc
Bag3 Fw: 5'-tccgaccaggttacattcccattc
Rev: 5'-gaggacgaggatgagcagtcag
ß-Gus Fw: 5'-gaaaatatgtggttggagagctcatt
Rev: 5'-ccgagtgaagatccccttttta
P: 5'-fam-ccagcactctcgtcggtgactgttca-tamra
Ccni Fw: 5'-agacagtttctgtggatgttcctc
Rev: 5'-agaagttggttgcaggccatacag
Dad1 Fw: 5'-cagcttcatcttagcggtttgc
Rev: 5'-ctgccagctcaagaattctgatcc
Dap Fw: 5'-aaagtcgctgggattcggattgtg
Rev: 5'-gctgttggatatgctgcgttcttg
NudC Fw: 5'- ttggttaccagtgaccccgaaatc
Rev: 5'- actgcaagagttcaggaaggtg
p19Arf Fw: 5'- tgcagattcgaactgcgagga
Rev: 5'-aggcatcgcgcacatccag
p53 Fw: 5'-tttgtgcctgtcctgggaga
Rev: 5'-ttccaaggcctcattcagctct
hPit-1 Fw: 5'- tgcaaactgaaagcaatattatcc
Rev: 5'-ttcttcgttttcttttcctttcattt
P: 5'-fam-atggctggaggaagctgagcaagtaggag-tamra
rPit-1, endogenous Fw: 5'-ccacagcgacaggacttcatta
Rev: 5'-aggggaggaaacccatgact
rPit-1 SI resist (wtPit/ Pit271) Fw: 5'-cgcaactggtttgcactaca
Rev: 5'-aggggaggaaacccatgact
PRL Fw: 5'-aattagccaggcctatcctgaagc
Rev: 5'-tggacaatttggcacctcagga
Rad17 Fw: 5'-aggaaggctgcctttagaacagac
Rev: 5'-tgaatcccaagctcctttgacag
Serinc3 Fw: 5'-gtgacgtgctggtcggttttaaag
Rev: 5'-attccaagagtgagccaggtctac
Sod2 Fw: 5'-gtgaacaatctgaacgtcaccgag
Rev: 5'-ttgcagtgggtcctgattagagc
Tnfrsf1a Fw: 5'-ggtggagatttctccttgcaaagc
Rev: 5'-aggaagataaccagaggcaacagc
Vcp Fw: 5'-tctggagccgattcaaaaggtg
Rev: 5'-atggctggatgctgatgacatctc
doi:10.1371/journal.pone.0120010.t001
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D5 in the four experiments, using the number of cells following doxycycline treatment relative
to that obtained without doxycycline.
Cell division rate was examined on cultured cells using the Click-iT EDU essay (Life Tech-
nologies), while cell death was evaluated using the Apoptag Tunel kit (Millipore). When using
the Click-iT EDU assay, EDU was added on day 3 of induction by doxycycline, 15–17 h before
fixing the cells. Labeled and unlabeled cells were counted from 6 micrographs taken at random
from duplicate wells and the experiment was repeated two (cell death assay) or three (division
rate) times.
Human pituitary adenoma culture
Human pituitary adenoma samples were obtained following surgical resection, following ap-
proval by the Ethics Committee of the University of Aix-Marseille II (France) and having ob-
tained written informed consent from each patient to participate in this study. Ten adenomas,
described in detail earlier [10], were used (A1-A6: somatotroph or somatolactotroph adeno-
mas, P1 and P2: prolactinomas, X2 and X3: nonfunctional adenomas). Methods for culture of
human pituitary adenomas have been described in detail [10]. Cells were infected after 5 days
of culture with lentiviral vectors at a multiplicity of infection of 10, in the presence of 8 μg/ml
Polybrene, resulting in an infection rate of 80–96% [16]. Viability assay, using Cell Titer-Glo
(Promega) was conducted 9 days post-infection.
Flow cytometry
For cell cycle analysis, cells were trypsinized, washed, fixed and permeabilized overnight using
70% ethanol at -20°C. Following centrifugation, cells were suspended in a solution containing
EDTA (20mM), Tween-20 (0.5%), RNAse (100 μg/ml) and propidium iodide (10 μg/ml,
Sigma). For dye-exclusion based viability assay, live cells were suspended, following trypsiniza-
tion and centrifugation, in normal medium containing To-Pro3 (75 nM, Life Technologies).
Analysis was performed on a BD FACS Canto analytical flow cytometer.
Statistical analysis
Results are presented as mean ± SEM. Statistical analysis by ANOVA followed by post-hoc
Tukey HSD test for multiple comparisons or by regression analysis was performed using the
OpenStat free statistical package (http://statpages.info/miller/OpenStatMain.htm).
Results
Conditional blockade and exchange of endogenous PIT-1
Our aims was to test the role of PIT-1 on the one hand, and to evaluate, on the other hand,
whether cell death observed upon expression of PIT271 [11] is related to its antagonization of
endogenous PIT-1 or is a direct action, independent of its interaction with endogenous PIT-1.
To achieve our aims, we used, as in the earlier studies, the GH4C1 rat somatolactotroph cell
line and we blocked endogenous Pit-1 using shRNA's on the one hand, or exchanged endoge-
nous PIT-1 for PITWT or PIT271 on the other hand. This latter exchange approach allowed to
evaluate the action of PIT271 independent of its interaction with endogenous PIT-1. However,
given that these modifications could result in cell death, we used conditional systems, relying
on expression vectors incorporating a modified doxycycline-regulated system (Fig. 1B.)
[15,17].
Conditional blockade of endogenous Pit-1 was obtained by expressing an shRNA specific
for rPit-1. First, the capacity of a panel of 4 siRNA commercialized by Ambion to block
Dual Role of PIT-1
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expression of Pit-1 was examined through transient transfection by measuring levels of
mRNA's by RT-qPCR (Fig. 2A). Based on this test, the three siRNA's that resulted in at least
50% inhibition of Pit-1mRNA expression were used to define shRNA sequences and build
pInducer-10 based lentiviral vectors allowing the conditional expression of shRNA. Follow-
ing infection and selection of GH4C1 cells by puromycin, the efficacies of the three lentiviral
constructs in term of blockade of Pit-1 expression upon induction of shRNA were compared
(Fig. 2B). At this step, sh2 turned out to have a somewhat lesser performance than the
other two constructs and was abandoned. After cloning of the GH4C1-sh1 and GH4C1-sh3
populations, the individual clones were compared (Fig. 2C). Clones displayed marked differ-
ences in term of leakage of the sh vector (inhibition of endogenous Pit-1 expression in the
absence of the inducer) as well as of activity following induction, and based on this compari-
son the clone GH4C1-sh1/1A2 (designated in the following as GH4C1-sh1) was finally
chosen for further work. Complementing the RT-qPCR results, we observed that the levels
of PIT-1 and PRL proteins were indeed very significantly decreased following the initiation
of doxycycline treatment (Fig. 2D). Note that measuring Prl expression in this and the
subsequent experiments allowed us to evaluate the functional effects of our experimental ma-
nipulations on the classical downstream targets of PIT-1 of which Prl was taken as an
example.
To exchange endogenous PIT-1 for exogenous PITWT or PIT271, the GH4C1-sh1 clone
obtained above was infected with a second pInducer-20 based lentiviral construct, similar to
the one used for the expression of the shRNA, but expressing neomycin resistance as selection
marker. This construct expressed conditionally, still in a doxycycline-dependent manner, ei-
ther PITWT or PIT271. Thus, exposure of the infected cells to doxycycline leads, in a single
step, to the blockade of the expression of endogenous PIT-1 and the expression of exogenous
PITWT or PIT271. Note that, to avoid interference of the shRNA with the expression of the ex-
ogenous construct, the sequences recognized by the shRNA's were modified in the latter, result-
ing in siRNA-resistant (SIR) Pit-1 or Pit271 constructs (Fig. 1C). This modification allowed
also, using specific primers (Table 1), to measure subsequently separately and compare the lev-
els of endogenous and exogenous (SIR) mRNA's.
The efficacy of this exchange is demonstrated in Fig. 2E (compare GH4C1/sh1/Pit271 vs.
GH4C1/sh1/Pit271+dox and GH4C1/sh1/PitWT vs. GH4C1/sh1/PitWT+Dox). The level of
expression of exogenous PITWT or PIT271 reached upon induction of the lentiviral vector is
about twice the expression of endogenous PIT-1 in control cells with no shRNA expression.
Note that the subsequent evaluation of protein levels by Western blots (see below) corroborat-
ed these results.
As shown previously, PRL expression fell by more than 90% in the cells (Fig. 2F) following
the induction of shRNA, despite the persistence of some endogenous PIT-1 expression (around
20% of normal levels, see Fig. 2E), indicating that this residual level of PIT-1 expression is not
sufficient to achieve a significant functional effect. The replacement of endogenous PIT-1 by
exogenous PITWT reinstated PRL expression (Fig. 2F), that reached a level of expression
higher than that observed in control cells, in accordance with the fact that the level of PITWT
expressed by the lentiviral vector following induction by doxycycline was also higher than the
level of endogenous PIT-1 in control cells. On the contrary, the replacement of PIT-1 by
PIT271 did not reverse the disappearance of PRL expression induced by the concurrent expres-
sion of shRNA (Fig. 2F).
For control purposes GH4C1 and CV1 cells expressing the same conditional PITWT and
PIT271 vectors have also been established.
Dual Role of PIT-1
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Fig 2. Development of GH4C1 cells clones with inducible expression of shRNA and/or PITWT and PIT271. A. Pit-1 mRNA levels in GH4C1 cells 48
hours after transfection of siRNA's (Ambion) specific for rat Pit-1. Results are expressed relative to levels found in Control ('Ctrl') cells corresponding to non-
transfected cells and correspond to the mean ± SEM of two experiments. 'Mock' corresponds to GH4C1 cells transfected with an unrelated non-specific
control siRNA. B. Time-course of PIT-1 mRNA levels following induction of shRNA expression in GH4C1 cells (polyclonal population) infected with shRNA
expressing conditional lentiviral vectors. Results are the mean ± SEM of two experiments and are expressed relative to levels found in Control ('Ctrl') cells
corresponding to GH4C1 cells infected with the sh1 expressing vector and not exposed to the inducer doxycycline. Induction was achieved by exposure to
1μg/ml doxycycline for 1 to 7 days. C. PIT-1 mRNA levels in individual clones of GH4C1 cells harboring the shRNA expressing conditional lentiviral vectors, 6
days after induction of shRNA expression by 1 μg/ml doxycycline. Results are expressed relative to values found for GH4C1 control cells. D. Western blots of
Dual Role of PIT-1
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Blockade of PIT-1 expression, but also over-expression of PITWT and
PIT271 interferes with cell growth
To evaluate global cell proliferation, the different cell lines obtained previously were cultured
in the absence or the presence of the inducer doxycycline. The treatment elicited the expected
changes in Pit-1 and Prl gene expression (Fig. 3A), consistent with what we have observed pre-
viously when developing the cell lines (Fig. 2E and 2F). Note in particular the decrease of the
expression of endogenous PIT-1 and of PRL following the induction of PIT271 in GH4C1
cells, consistent with its known dominant negative character. Doxycycline treatment has no ef-
fect on its own on the different parameters examined as shown by the results obtained for the
parent GH4C1 cells (see Figs. 3 and 4).
Inhibition of the expression of endogenous Pit-1 following induction of shRNA led to a
slight, but significant, inhibition of cell growth on its own (Fig. 3B central panel and 3C). This
effect was reversed by the expression of exogenous PITWT. Note that, while the results pre-
sented on Fig. 3B and 3C were obtained using sh1/A2, the same inhibition of cell growth was
observed with GH4C1 cells harboring the unrelated sequence sh3 (clone sh3/A3; results not
shown).
Expression of PIT271 in GH4C1 cells led to an inhibition of cell growth that was markedly
stronger than that seen when the expression of endogenous PIT-1 was blocked by the shRNA
(Fig. 3B and 3C). This effect of PIT271 was present also when its expression was induced con-
currently with the induction of shRNA and the resulting inhibition of the expression of endog-
enous PIT-1 (Fig. 3B central panel), suggesting that the effect of PIT271 is independent from
its possible interaction with, and blockade of, PIT-1. Finally the non-pituitary cell line CV1
was unaffected by the expression of either PITWT or PIT271 (Fig. 3B right panel).
The slower growth induced by the shRNA or by PIT271 could be related to an increase in
cell death, a decrease in cell division rate or both. In our previous work we documented that
PIT271 induced cell death in GH4C1 cells that was accompanied by DNA fragmentation, sug-
gesting the existence of apoptosis [11]. Using Tunel assay, we examined whether it is also the
case when endogenous PIT-1 expression is blocked or when PIT271 is expressed in the absence
of endogenous PIT-1 (Fig. 3D). The blockade of PIT-1 expression by shRNA did not increase
the proportion of Tunel-positive cells. On the contrary the expression of PIT271 led to a signif-
icant increase of Tunel labeling in GH4C1 cells, confirming our previous results. Similar to its
effect on cell proliferation, the action of PIT271 on DNA fragmentation was independent on
the expression of endogenous PIT-1, as it was observed also in cells in which endogenous PIT-
1 expression was blocked by shRNA. Surprisingly, expression of exogenous PITWT, resulting
in a higher than normal total PIT-1 expression in the cells (Fig. 3A) led also to a significant in-
crease in Tunel labeling.
To examine cell division, we evaluated the incorporation of a cell division marker, EDU, in
the different populations of cells and under different conditions (Fig. 3E). Cell division rate
was markedly decreased by PIT271, both in the presence or absence of expression of endoge-
nous PIT-1. The inhibition by shRNA of endogenous PIT-1 led in itself to a decrease of cell di-
vision rate, of comparable magnitude as that observed with PIT271, and this decrease was
control GH4C1 cells and GH4C1/sh1 A2 clone. Induction by 1 μg/ml doxycycline was maintained for 3 or 7 days. Molecular weight ladder (Thermo Page
Ruler) on the right. E. Expression of mRNA's for PIT-1 or PIT271 in the different cell lines in the absence or presence of 1 μg/ml doxycycline for 6 days. 'Pit
endo' corresponds to wt endogenous PIT-1, ‘Pit SIR’ (si-resistant) to PITWT or PIT271 expressed from the conditional expression vectors. The results for 'Pit
endo' and ‘Pit SIR’ have been obtained by normalizing the values obtained in qPCR to those obtained with known quantities of external controls, and are thus
comparable. Results are mean ± SEM of three measures. F. Expression, in the same cells as in Fig. 2E, of PRL mRNA's. Results are expressed relative to
values found for GH4C1 control cells.
doi:10.1371/journal.pone.0120010.g002
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significantly reversed, albeit not totally, by the expression of exogenous PITWT. However, and
somewhat paradoxically, the overexpression of PIT-1 in GH4C1 cells led also to a significant,
though milder, depression of cell division.
To confirm these results by a different approach, we have performed, in a separate set of ex-
periments, an analysis by flow cytometry. The results of this analysis (Fig. 4) confirmed those
detailed above and reproduced closely the results shown on Fig. 3D, showing an increase of cell
death (increase of the proportion of sub-G1 population) by PIT271 and, to a lesser extent, by
PITWT overexpression. Conversely, cell division (proportion of the S+G2/M population) was
decreased in the same conditions, but also by the blockade of endogenous PIT-1 expression, re-
producing the results we have obtained using EDU incorporation (Fig. 3E). Finally, viability of
the cells was found to be decreased by the expression of PIT271 or PITWT, but also by the
blockade of the expression of endogenous PIT-1.
Dose-dependence of the effects of shRNA, PITWT and PIT271
We examined whether the effects of shRNA, PITWT and of PIT271 are dependent on the level
of expression of these factors. For that, we first checked whether the level of their expression
could be modulated by the concentration of doxycycline during induction. We observed indeed
that the degree of induction was strictly dose-dependent between 0 and 1000 ng/ml doxycy-
cline (Fig. 5A). The increasing level of transcription of the transgenes was accompanied by par-
allel changes in the levels of PIT-1 protein and in the expression its target PRL (Fig. 5B and
5D). Moreover, we observed, using GH4C1/sh1 cells and flow-cytometry, that the expression
of RFP (the transcription of which is under the control of the same promoter as that for the
above transgenes, see Fig. 1A) presented a unimodal distribution at all doxycycline concentra-
tions, with an increase of the mean level of expression with increasing doxycycline concentra-
tions (Fig. 5C). This indicates that the increase in the transcription of the transgenes with
increasing levels of the inducer, as observed by the global analyses done by RT-qPCR or West-
ern-blots, was related to a graded effect in the individual cells of the population, rather than to
an all-or-none effect affecting a small subpopulation that would be more sensitive to the induc-
er and the proportion of which would increase with increasing doses of doxyxycline.
The magnitudes of the death-inducing effect of PITWT or PIT271 as well as of the decrease
of division rate induced by PIT271 and the blockade of expression of endogenous PIT-1 by
shRNA were all dependent on the level of expression of the transgenes as induced by increasing
Fig 3. Effects of PITWT, PIT271 and/or shRNA for PIT-1 on the proliferation and survival of GH4C1 cells. A. Expression of mRNA's for PIT-1 or PIT271
(upper panel), as well as for PRL (lower panel), in the different cell lines in the absence or presence of 1 μg/ml doxycycline for 5 days. The cells used were
from the same experiment as those grown on parallel plates to measure proliferation rate (Fig. 3B). Results for 'Pit endo' and ‘Pit SIR’ have been obtained by
normalizing the values obtained in qPCR to those obtained with known quantities of external controls, and can thus be compared. Values correspond to
mean ± SEM (n = 3). The significance of the effect of docycycline-induction on the expression of endogenous PIT-1, of the transgene or PRL was evaluated
by the Student's t-test. +: p<0,05; ++: p<0,01; +++: p<0,001. B. Effect of the expression of PITWT, PIT271 and/or shRNA for PIT-1 on the proliferation of
GH4C1 or GH4C1-sh1 cells as well as on CV1 cells. Cells were counted on triplicate wells. Induction of the expression of the shRNA (GH4C1-sh1 cells) and
of the transcription factors was started on day 0 and continued throughout the experiment. 'Ctrl' represent GH4C1, GH4C1-sh1 or CV1 cells not infected with
pInducer-20 vector expressing a transcription factor. Counting of CV1 cells was discontinued after 5 days, as cells became too confluent. Values correspond
to mean ± SEM (n = 3). C. Effect of the expression of PITWT, PIT271 and/or shRNA for PIT-1 on the proliferation of GH4C1 or GH4C1-sh1 cells. Data
represent the pooled results of the four experiments (with triplicate wells in each) of which one is illustrated on Fig. 3B, and correspond to the cell numbers
found in the absence or the presence of doxycycline five day (D5) after the start of the induction. Mean ±SEM, +: p<0,05, ++: p<0,01, relative to the same
population without doxycycline, *: p<0,05. D. Effect of the expression of PITWT, PIT271 and/or shRNA for PIT-1 on DNA fragmentation as evaluated by
Tunel assay following 4 days exposure to doxycycline. Labeled and unlabeled cells were counted from 6 micrographs taken at random from duplicate wells
and the experiment was repeated twice. Mean ±SEM, +: p<0,05, relative to the same population without doxycycline. E. Effect of the expression of PITWT,
PIT271 and/or shRNA for PIT-1 on the division of GH4C1 or GH4C1-sh1 cells using EDU as cell division marker. EDU was present for 15–17h between day 3
and 4 of the induction by doxycycline. Labeled and unlabeled cells were counted from 6 micrographs taken at random from duplicate wells and experiments
were repeated three times. Numbers given within the columns correspond to the population doubling time in hours as calculated from the labeling
percentages. Mean ±SEM, +: p<0,05, ++: p<0,01, relative to the same population without doxycycline, **: p<0,01.
doi:10.1371/journal.pone.0120010.g003
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doses of doxycycline, and increased as the level of induction increased. The correlation with
the dose of doxycycline was statistically significant for each of these effects. Moreover, the ef-
fects were observable even at the lowest dose (20 ng/ml) of the inducer (Fig. 5E), and we could
not observe a threshold level of induction under which there would be no effect on cell death
and/or division. Finally, the results show that PIT271 is considerably more potent in inducing
death of the cells than PITWT. Taking the example of cells grown in the presence of 100 ng/ml
doxycycline, cell death was found to be twice as important when PIT271 was induced (compare
the proportion of the Sub-G2 population in GH4C1/PITWT and GH4C1/PIT271 cells,
Fig. 5E), although the level of PIT271 can be estimated to be only half of that of PITWT
(Fig. 5A and 5D).
Mechanisms of cell death induced by PITWT or PIT271
To get some insight into the mechanisms of the cell death induced by the overexpression
of PITWT and by PIT271 that we have observed in our previous experiments, we tried to
block these effect by pharmacologic inhibitors considered to target specific kinds of cells
Fig 4. Flow cytometer analysis of the different cell populations in the absence or presence of 1 μg/ml doxycycline for 5 days. A. Representative
examples of histograms based on DNA content showing the decrease of the proportion of the S+G2/M population upon induction of shRNA or PIT271, with
the concurrent increase in the sub-G1 population in the latter case. B. Quantitative analysis of the different sub-populations. Results (mean ± SEM) are
pooled from four independent experiments, with duplicate measures in each. +: p<0,05, ++: p<0.01, relative to the same population without doxycycline,
*: p<0,05, **: p<0,01.
doi:10.1371/journal.pone.0120010.g004
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Fig 5. Dose-dependence of the actions of shRNA, PITWT and PIT271. A. Dose-responses curves of mRNA's for PIT-1 and PRL, in the different cell lines
grown in presence of different doses (0, 20, 40, 100 or 1000 ng/ml) of doxycycline for 5 days. Results for 'PIT endo' and ‘PIT SIR’ have been obtained by
normalizing the values obtained in qPCR to those obtained with known quantities of external controls, and can thus be compared. The values at 'Ctrl'
correspond to the levels measured in cells exposed to 0 ng/ml doxycycline. The results correspond to the mean ± SEM of three independent measurements.
B. Western blots for cells included in the experiment depicted in Fig. 5A. C. Representative examples of histograms based on the fluorescence of RFP as
evaluated by flow cytometry in GHC1/PITWT cells grown in presence of different doses of doxycycline for 5 days. D. Quantitation of Western blots of Fig. 5B.
Bands of the protein of interest were normalized relative to actin and expressed as percentage of control cells grown in the absence of doxycycline. Legends
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death: Z-VAD-FMK, a general caspase inhibitor blocking caspase-dependent apoptosis, chlo-
roquine, targeting autophagy, and two drugs blocking necrosis, IM-54 and necrostatin-1.
Drugs were present throughout the induction of PITWT or PIT271. The effects of the drugs
were tested by examining the increase of the sub-G1 population following induction of PIT271
or PITWT in GH4C1 cells, without expression of shRNA, to avoid a possible interference from
the blockade of endogenous PIT-1 expression. However, none of the drugs tested modified sig-
nificantly the induced cell death (Fig. 6.). It can be noted that Z-VAD-FMK itself induced cell
death in control cells, as judged by the increase of the proportion of the sub-G1 population,
similar to what has been observed for some other cell types [18–20]. However, PIT271 or
PITWT induced a marked cell death that was clearly superimposed on that induced by the
drug alone.
In a previous study we have identified, using ChIP-Chip, a number of putative direct targets
of PIT-1 [21]. We examined, using RT-qPCR, whether genes known to be involved in various
cell death mechanisms and/or cell division and identified in these experiments (Aatf, Bag1,
Bag3, Ccni, Dad1, Dap, Nudc, Rad17, Serinc3, Sod2, Tnfrsf1a and Vcp) were activated during
the induction of cell death by PIT271 or PITWT. However, we could not detect any significant
change in the expression of any of these factors following the induction of either PITWT or
PIT271. Neither could we detect any activation of P19ARF or P53, described earlier to be in-
volved in the cell death induced by a RET-PIT-1 pathway [12], be it by RT-qPCR or by West-
ern blots, using the same antibodies as those authors as well as another antibody.
are the same as for Fig. 5A. E. Dose-response curves for the proportions of the sub-G1 and the S+G2M populations in the different cell lines grown in
presence of different doses (0, 20, 40, 100 or 1000 ng/ml) of doxycycline for 5 days. The values at 'Ctrl' correspond to the levels measured in cells exposed to
0 ng/ml doxycycline. The results are given as mean ± SEM (n = 3), significant correlations (**: p<0.001) are indicated beside the corresponding curves.
Legends are the same as for Fig. 5A. Pearson coefficient of correlations were for Sub-G1 results: GH4C1/PIT271: r = 0,9449 (df = 10), GH4C1/PITWT: r =
0,8144 (df = 13), GHC1/sh1/PIT271: r = 0,9668 (df = 13) and for M+G2M results: GHC1/PIT271: r = -0,8044 (df = 13), GH4C1/sh1: r = -0,9615 (df = 13),
GH4C1/sh1/PIT271: r = -0,9802 (df = 10).
doi:10.1371/journal.pone.0120010.g005
Fig 6. Effect of antagonists of different types of cell death on the PITWT or PIT271 induced cell death.
The proportion of sub-G1 population was evaluated by flow cytometry. Drugs were Z-VAD-FMK (25 μM), a
general caspase inhibitor; chloroquine (10 μM), an inhibitor of autophagy; IM-54 (10 μM) and necrostatin-1
(10 μM), inhibitors of necrosis. Flow cytometry was performed 4 days after the addition of the drugs together
with 1 μg/ml doxycycline. Results (mean ±SEM) are pooled from two independent experiments, with triplicate
measures in each. +: p< 0,05, ++: p< 0,01 relative to the same population without doxycycline; *: p< 0,05,
**: p< 0,01 relative to the same condition in the absence of drug.
doi:10.1371/journal.pone.0120010.g006
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Decrease of viability of human tumor cells by PITWT
We have recently shown that PIT271 induces, similar to what we have observed previously in
the GH4C1 cell line [11], death of primary human tumor cells [10]. We wished to test whether
the adverse effect of PITWT on cell viability described here could also be reproduced in such
tumor cells. Cells were infected with an hPITWT-expressing lentiviral vector and the influence
on viability and cell death was explored 9 days post-infection. Note that, considering the very
large variations of the different parameters among different tumors, results are given individu-
ally for each tumor. The infection led to a clearcut, though variable among tumors, increase in
the quantities of PIT-1 mRNA (Fig. 7A) that was highly significant (t = 5,39, ddf = 9, p = 0,004,
using Student's t-test for paired data). Note that in these experiments we could not separate
transcription of Pit-1 from the lentiviral vector from the transcription of endogenous Pit-1.
While the reaction of the different adenomas was variable, altogether there was a significant de-
crease of viability of the somatolactotroph/lactotroph adenomas following infection with the
hPITWT expressing lentiviral vector as compared to cells infected with an eGFP expressing
vector (Fig. 7B). The magnitude of this effect was comparable to that observed previously fol-
lowing the transduction of hPIT271 [10] and does not seem to correlate with the level of en-
dogenous hPITWT expression (in the absence of infection) of the individual tumors (Fig. 7A).
Viability of non-functional adenomas was not significantly affected by the expression of
PITWT.
Discussion
The present study reconciles the two, seemingly divergent, sets of results reported in the litera-
ture, and shows that PIT-1 is indeed required for the maintenance of somatolactotroph cells, as
suggested by the initial observations of Castrillo et al. [9], but that it can also, when overex-
pressed, decrease cell proliferation and induce cell death, confirming thus the results reported
by the group of C.V. Alvarez [12,13]. The decrease of cell viability induced by PIT-1 could be
observed not only in the rat GH4C1 somatolactotroph cell line, but also in primary human
somatolactotroph tumor cells. A further finding of our study is that while PIT271 induces both
a decrease of cell division and death of the cells, confirming our earlier results [11], these ef-
fects, at variance with earlier interpretations, including ours, are independent of the presence
of PIT-1 in the cells, i.e. are not the result of a blockade of PIT-1's action by PIT271.
Fig 7. Effects of hPITWT on the viability of primary human pituitary tumor cells. A. Expression of
mRNA's for PIT-1 in individual tumor populations following infection with the control, eGFP-expressing
lentiviral vector or with the hPITWT expressing lentiviral vector. The global increase in the expression of PIT-
1 mRNA following the infection was statistically significant (paired t-test, p<0,005). B. Viability of individual
tumor populations following infection with the hPITWT expressing lentiviral vector, expressed relative to the
viability following infection with the control, eGFP-expressing lentiviral vector, as evaluated by the Cell Titer-
Glo assay. Mean ± SEM (n = 3), +: p< 0,05, ++: p< 0,01.
doi:10.1371/journal.pone.0120010.g007
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This study was made possible by the development of a new cellular model based on the utili-
zation of inducible lentiviral vectors, and permitting the silencing of endogenous PIT-1
through the expression of a specific shRNA on the one hand, and the expression of exogenous
normal or mutant PIT-1 on the other hand. In particular, by combining the two kinds of vec-
tors, we were able to exchange the expression of endogenous PIT-1 for an exogenous factor.
More generally, our results demonstrate that this approach may be used to exchange, in an in-
ducible, dose-dependent and reversible manner, an endogenous transcription factor (or, as a
matter of fact, any protein) for a mutant variant in cultured cells, allowing the study of the lat-
ter without interference by the endogenous wild type factor.
The molecular data obtained for the characterization of this model are in agreement with
the known effects of PITWT and PIT271 and validate the model. Thus, blockade of the expres-
sion of endogenous PIT-1 leads to a dose-dependent decrease, and eventually collapse, of the
expression of its target PRL. Further, expression of PIT271 in GH4C1 cells leads to the dose-de-
pendent decrease of the expression of both PIT-1 and of PRL, confirming its dominant nega-
tive character [4,11,22]. Note that following the expression of shRNA or PIT271 in the cells the
expression of PRL fell more precipitously than that of PIT-1 (see Fig. 5).
Our results show that an approximately twofold increase of PIT-1 expression (see Fig. 3A)
induces mortality of somatolactotroph cells. This induction of cell death by PIT-1 seems to be
less important in our hand than that reported by C.V. Alvarez [12,13]. However, the compari-
son is not straightforward, as in those publications the quantitation of cell death was based on
counting the proportion of cells with condensed and fragmented chromatin, while we used
flow cytometry or Tunel reaction. More importantly, the level of PIT-1 reached in their experi-
mental setup is likely to be significantly higher (they document a tenfold increase in Pit-1
mRNA, while with our conditions this increase, as well as that of the level of the protein itself,
is around twofold), but only transient, peaking at 24h post-transfection and returning to con-
trol levels 48h post-transfection, when cell death was evaluated, while in our hand there is an
elevated level of Pit-1mRNA lasting the whole duration of the experiment, in the present case
5–7 days. Nevertheless, our two sets of studies are in agreement as to the general, qualitative as-
pect of the effect of PIT-1.
The mechanisms of the cell death induced by PIT-1 overexpression, and the same can be
said concerning of the cell death induced by PIT271 (see also below), are at this point not clear.
Indeed, in the present experiments we have been unable to identify the direct target(s) on
which PIT-1 (or PIT271) acts and that set in motion the process leading to cell death. Thus, we
could not observe a modification of the level of expression of a number of potential direct tar-
gets of PIT-1 identified in our earlier work [21]. We have also been unable to confirm the in-
crease of P19ARF expression reported earlier [12,13], be it at the level of its mRNA or the
protein. Differences in the experimental conditions (in particular 24 to 48 h deprivation of
serum in the experiments of Alvarez et al. [12,13], presence of normal concentrations of serum
in ours) might explain this discrepancy. Further studies will be needed to identify the immedi-
ate targets of PIT-1 or PIT271 that are responsible for the initiation of the death process in the
present conditions. Besides the primary targets, the question of the death mechanisms involved
remains also open. Concerning the type of cell death elicited by PIT-1 or PIT271, our results
suggest that it is not related to an autophagic or necrotic process, and the increase of Tunel la-
beling suggests an apoptotic, although caspase-independent, mechanism, as shown earlier for
the cell death induced by PIT271 [11]. This mechanism seems to be at play not only in GH4C1
cells, but also in human somatolactotroph adenomas, as in a preliminary experiment using two
such adenomas, we observed that hPITWT expression increases Tunel-labeling in these cells
(results not shown). Given the simultaneous increase of cell death and decrease in division rate
induced by PIT-1 or by PIT271, we expected to confirm the involvement of P53 in this process,
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and the lack of change in P53 expression in the present experiments following induction of
PITWT or PIT271 is somewhat surprising. Indeed, P53 is an important hub in the regulatory
network mediating the increase of cell death and concurrent decrease of cell division observed
in situations of genotoxic stress or disruption of certain signaling pathways [23,24]. However,
activation of p53 involves also various post-transcriptional modifications as well as interaction
with cofactors, and future studies will have to investigate whether PIT-1 overexpression or
PIT271 activate the P53 pathway through such mechanisms.
Maintenance of division of GH4C1 cells requires a normal expression of PIT-1 as shown by
the marked fall in proliferation rate when expression of endogenous PIT-1 is blocked by
shRNA. This action of shRNA is not accompanied by cell death, indicating that the mecha-
nisms involved in this effect are different from those at play in the proliferation-depressing ac-
tion of elevated PIT-1 that include also cell death. Basal PIT-1 level might directly regulate, in
normal cells, expression of some yet to be identified gene(s) involved in cell division to main-
tain normal proliferation rate. On the other hand, PIT-1 is known to interact with a large num-
ber of transcription factors and cofactors, some of which are involved in the regulation of the
proliferation of pituitary cells [25–29] and interactions with some of these factors, or other yet
to be identified factors may be involved in the proliferation-maintaining action of PIT-1.
Taken globally, our result suggest that there is an optimal level of PIT-1 expression in
GH4C1 cells and that any deviation from this set point, even if relatively moderate, have detri-
mental consequences for cells, a downward shift leading to a marked decrease of cell division
rate, and an upward deviation to cell death accompanied by some decrease of cell division.
Thus, besides its well-characterized role in regulating its hormonal targets, PIT-1 seems to be
involved in the maintenance of proliferative activity on the one hand, and in the death of the
cells expressing it at high level on the other hand. This differential action of PIT-1 may be de-
termined by a concentration-dependent binding to recognition sequences of different affinities
and/or by a concentration-dependent interactions with different cofactors, as documented for
other transcription factors [30–34].
Physiology may offer a clue to understand the biological significance of this Janus-faced
function of PIT-1. Indeed, there is, in the developing pituitary, an early postnatal wave of divi-
sion of somatolactotroph cells [35,36], resulting in the marked expansion of this population.
During late pregnancy and lactation, the lactotroph population expands secondarily though
cell division [37], while at weaning there is an involution of this population, in part through
cell death [38–41]. It can be hypothesized that PIT-1 participates, through its dual function, in
both of these processes. Thus it could contribute to maintain the proliferation of the somatolac-
totroph population during development or lactation. On the other hand, an elevated PIT-1 ex-
pression, possibly induced by RET [12,13,38], might be instrumental in triggering the post-
weaning decrease of lactotrophs through cell death. Note, however, that cell death seems to be
more sensitive to the levels of PIT-1, being elevated already for a slight (around 20%) increase
in intracellular PIT-1 level, while for cell division to decrease noticeably the expression of PIT-
1 must diminish by 60–80% (Fig. 5.). This observation suggests that the primary effect of PIT-
1, besides the regulation of the expression of its classical hormonal targets, such as Prl, Gh or
Tsh, might be the regulation of cell death.
For PIT271, our results show that its cell-death inducing effect is unrelated to an antagoni-
zation of the action of endogenous PIT-1. Indeed, on the one hand cell death is induced even
in the absence of expression of endogenous PIT-1, and on the other hand the blockade of PIT-
1 expression by shRNA by itself does not induces death of the cells. One could argue that the ef-
fect of PIT271 in the GH4C1/sh1/PIT271 cells is related to its antagonization of the residual
PIT-1 that exists in the cells even following the maximal induction of the shRNA. However,
this residual expression of PIT-1 seems to be too low to have a functional effect, as judged by
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the level expression of PRL (Fig. 5). Moreover, cell death induced by PIT271 at low doses of
doxycycline is of the same magnitude in the GH4C1/PIT271 and the GH4C1/sh1/PIT271 cells,
even though the ratio of PIT271 to endogenous PIT-1 protein in the cells is very different in
these two cases, as shown by the inspection of Fig. 5. This support our hypothesis that the
death-inducing effect of this mutant is an action of its own, independent of its dominant nega-
tive character, and similar to that of PIT-1. Conversely, at this point we cannot exclude that the
strong decrease in cell division elicited by the expression of PIT271 is explained by an interac-
tion/competition with endogenous PIT-1, as the same effect, of approximately the same magni-
tude, can be observed when the expression of endogenous PIT-1 is blocked by shRNA.
The question that arises then is whether the cell death induced by the expression of PIT271
or by the overexpression of PIT-1 are mediated by the same mechanisms. From a phenomeno-
logical point of view, the global characteristics of the cell death induced by these two variants of
PIT-1 seem to be similar (see above). However, the magnitude of cell death is considerably
larger when induced by PIT271, despite a similar level of expression of PIT-1 and PIT271 fol-
lowing the induction (see Figs. 3A, 5A, 5B, 5D). This observation suggests that either PIT271
influences the same targets as PIT-1 but, related maybe to the R271Wmutation, has a greater
efficacy, or that the two have different mechanisms of actions. An indirect argument in favor of
a common mechanism is that the cell-death inducing effect of PITWT and PIT271 are both
specific for somatolactotroph cells and cannot be observed in other cell types. However, this
point will need to be clarified by further studies aiming at elucidating and comparing the mo-
lecular mechanisms of the action of PIT-1 and PIT271.
PIT271 is considered as a dominant negative mutant of PIT-1, as heterozygote patients, i.e.
expressing one normal allele of PIT-1 besides the mutant allele, suffer from CPHD. Note that
the GH4C1/PIT271 cells exposed to 40 ng/ml doxycycline mimic this situation, as in this con-
dition, in which we have a threefold increase in cell death (see Fig. 5E) we can estimate to have
about half the normal level of endogenous PIT-1 and an equivalent expression of PIT271 in the
cells. The mechanism of this effect is not clear, however. It was hypothesized that it could be ex-
plained by PIT271 interfering with the formation of productive PIT-1 dimers on its target pro-
moters [42] and/or by the defective recruitment of cofactors on the promoter as documented
for a closely related mutant, PIT-1(R271A) [43]. According to these hypothesis, PIT271 could
schematically considered as competing out endogenous PIT-1 and its pathological effect would
be related to a overall loss of PIT-1’s efficacy due to this competition. Our present result dem-
onstrate that PIT271 has major physiological effects—induction of cell death, possibly decrease
of cell division- that are specific to this mutant, and independent of the presence of, and inter-
actions with, PIT-1. These effects can very well explain the pathogenic influence of PIT271,
without the need to invoke a competition with PIT-1, as they can lead on their own to the loss
of the somatolactotroph cell population characterizing the patients carrying this mutation,
and, as our results show, this effect would be present even in the presence of an expression of
an equivalent level of PIT-1, as it is the case in heterozygote patients. On the other hand, it
must be stressed that PIT271 does decrease the activation by PIT-1 of its target genes Prl and
Gh (see Figs. 3A, 5A, 5B and 5D for its action on Prl or [11]) and thus have also a true domi-
nant negative “competitive” action. This action could contribute to the observed clinical traits
of CPHD in patients.
A final noteworthy aspect of our result is the cell-type specificity of the observed effects. In-
deed the blockade of cell proliferation by PIT-1 or of PIT271 is specific for somatolactotroph
cells, and we could observe no effect in CV1 or non-somatolactotroph human tumor cells
(present study), or, for PIT271, in HeLa cells [11]. This suggests that this action is dependent
on specific cell-type dependent conditions and may require the cooperation with a
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somatolactotroph cell-specific factor. Experiments are in progress in our laboratory to identify
factors that might explain this specificity.
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